Total Liabilities for Bristol-Myers Squibb (BMY)
According to Bristol-Myers Squibb's latest reported financial statements, the company's latest reported total liabilities is $71.53B USD. Total liabilities sum everything the company owes at the end of each reporting period — accounts payable, accrued expenses, debt, lease obligations, and other claims — as filed on the balance sheet. Compare with total assets and net assets for solvency context.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingTotal LiabilitiesSwitch metric
Latest period
$71.53B
YoY change
-6.1%
5Y CAGR
-2.4%
Peak year (2020)
$80.60B
Latest annual
$71.53B
Total Liabilities history chart for Bristol-Myers Squibb (BMY) from 1987 to 2025
Total Liabilities history table for Bristol-Myers Squibb (BMY) from 1987 to 2025
| Fiscal year | Period ended | Reported | Total Liabilities | YoY |
|---|---|---|---|---|
| 2025 | $71.53B | -6.1% | ||
| 2024 | $76.22B | +16.1% | ||
| 2023 | $65.67B | -0.0% | ||
| 2022 | $65.70B | -10.4% | ||
| 2021 | $73.31B | -9.0% | ||
| 2020 | $80.60B | +3.0% | ||
| 2019 | $78.25B | +275.1% | ||
| 2018 | $20.86B | -3.9% | ||
| 2017 | $21.70B | +25.0% | ||
| 2016 | $17.36B | +0.2% | ||
| 2015 | $17.32B | -7.7% | ||
| 2014 | $18.77B | -19.7% | ||
| 2013 | $23.36B | +4.9% | ||
| 2012 | $22.26B | +30.1% | ||
| 2011 | $17.10B | +10.8% | ||
| 2010 | $15.44B | -4.8% | ||
| 2009 | $16.22B | -6.1% | ||
| 2008 | $17.28B | +10.7% | ||
| 2007 | $15.61B | +0.2% | ||
| 2006 | $15.58B | -8.0% | ||
| 2005 | $16.93B | -16.3% | ||
| 2004 | $20.23B | +14.6% | ||
| 2003 | $17.66B | +8.6% | ||
| 2002 | $16.27B | -13.2% | ||
| 2001 | $18.74B | +123.1% | ||
| 2000 | $8.40B | -0.8% | ||
| 1999 | $8.47B | -2.6% | ||
| 1998 | $8.70B | +12.1% | ||
| 1997 | $7.76B | -4.4% | ||
| 1996 | $8.12B | +0.1% | ||
| 1995 | $8.11B | +12.5% | ||
| 1994 | $7.21B | +17.0% | ||
| 1993 | $6.16B | +28.8% | ||
| 1992 | $4.78B | +32.1% | ||
| 1991 | $3.62B | -4.6% | ||
| 1990 | $3.80B | +11.3% | ||
| 1989 | $3.41B | +2.6% | ||
| 1988 | $3.33B | +20.5% | ||
| 1987 | $2.76B | — |
Total Liabilities values are taken from Bristol-Myers Squibb's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Bristol-Myers Squibb (BMY) total liabilities totalled $71.53B – declined 6.1% year-over-year.
Over 2020–2025 (5 years), Bristol-Myers Squibb total liabilities expanded at a -2.4% compound annual rate, with a net decline across the window.
The dataset's maximum total liabilities sits at $80.60B (2020); the minimum reading of $2.76B dates to 1987.
Among 8 Healthcare peers, Bristol-Myers Squibb (BMY) ranks 8th; the peer median for total liabilities is $101.80B.
Bristol-Myers Squibb Total Liabilities by Year
Bristol-Myers Squibb Total Liabilities 2025: $71.53B
Bristol-Myers Squibb total liabilities in 2025 was $71.53B, declined 6.1% below 2024.
Bristol-Myers Squibb Total Liabilities 2024: $76.22B
Bristol-Myers Squibb total liabilities in 2024 was $76.22B, grew 16.1% from 2023.
Bristol-Myers Squibb Total Liabilities 2023: $65.67B
Bristol-Myers Squibb total liabilities in 2023 was $65.67B, edged down 0.0% below 2022.
Bristol-Myers Squibb Total Liabilities 2022: $65.70B
Bristol-Myers Squibb total liabilities in 2022 was $65.70B, declined 10.4% below 2021.
Bristol-Myers Squibb Total Liabilities 2021: $73.31B
Bristol-Myers Squibb total liabilities in 2021 was $73.31B.
See more financial history for Bristol-Myers Squibb (BMY).
Sector peers — Total Liabilities
Companies in the same sector as Bristol-Myers Squibb, ranked by their latest total liabilities.
| Company | Total Liabilities | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $348.86B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $207.88B | Healthcare |
| AbbVie Inc. (ABBV) | $137.19B | Healthcare |
| Johnson & Johnson (JNJ) | $117.67B | Healthcare |
| Eli Lilly and Company (LLY) | $85.94B | Healthcare |
| Merck & Co., Inc. (MRK) | $84.20B | Healthcare |
| Amgen Inc. (AMGN) | $81.93B | Healthcare |
| AstraZeneca PLC (AZN) | $65.36B | Healthcare |
Frequently asked questions
What is Bristol-Myers Squibb's total liabilities?
- Latest reported total liabilities for Bristol-Myers Squibb (BMY) is $71.53B (period ending December 31, 2025).
How has Bristol-Myers Squibb total liabilities changed year-over-year?
- Bristol-Myers Squibb (BMY) total liabilities changed -6.1% year-over-year on the latest annual filing.
What is the long-term growth rate of Bristol-Myers Squibb total liabilities?
- Bristol-Myers Squibb (BMY) total liabilities compound annual growth rate is -2.4% over the most recent 5 years available.
When did Bristol-Myers Squibb total liabilities hit its highest annual value?
- Bristol-Myers Squibb total liabilities reached its highest annual value of $80.60B in 2020.
What was Bristol-Myers Squibb total liabilities in 2024?
- Bristol-Myers Squibb (BMY) total liabilities in 2024 was $76.22B.
What was Bristol-Myers Squibb total liabilities in 2025?
- Bristol-Myers Squibb (BMY) total liabilities in 2025 was $71.53B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
BMY Overview
Company profile, financial tools, and key metrics
BMY Revenue Counter
Earns $1,528 every second. See per minute, hour, and day.
BMY Earnings Counter
Earns $223.65 per second net profit. See per minute, hour, and day.
BMY Economic Scale
Exceeds Bahrain's GDP. Compare with world economies.
BMY What If Invested
What if you had invested $1,000? See historical returns from any date.
BMY How It Makes Money
Discover visual breakdown of $48.19B in revenue — where it comes from and where it goes.
BMY Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
BMY Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
BMY Daily Price Character
Steady · 47.3% historical win rate (green days). Streaks & record days.
BMY Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
BMY Stock Split History
6 splits on record. Dates, ratios, and cumulative multiple.
BMY Dividend Profile
Yield: 4.34%. Safety: 7/8. See full history.
BMY Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
BMY Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.